World Health Organization's response to the COVID-19 pandemic

AHF: Six Reasons Why WHO Chief Should Go

Retrieved on: 
Wednesday, June 23, 2021
LGBTQ+, Biotechnology, FDA, AIDS, Other Health, Health, Public policy, Pharmaceutical, Infectious diseases, Public policy, Government, Consumer, World Health Organization, Public health, Articles, Health, Tedros Adhanom, United Nations, Ghebreyesus, Director-General of the World Health Organization, Tedros, World Health Organization's response to the COVID-19 pandemic, Roopa Dhatt

The appointment of the next WHO Director-General is slated for May 2022 after the current WHO chief, Tedros Adhanom Ghebreyesus, completes his first term by the end of 2021.

Key Points: 
  • The appointment of the next WHO Director-General is slated for May 2022 after the current WHO chief, Tedros Adhanom Ghebreyesus, completes his first term by the end of 2021.
  • Extraordinary circumstances call for extraordinary leadership, which is why we need a new candidate to head up the WHO.
  • The following six reasons underscore why WHO needs a new Director-General:
    1. WHO delayed declaring COVID-19 a pandemic.
  • Member States can submit the names of possible candidates to the WHO Executive Board until mid-September 2021 .

Global WholeHealth Partners Corp (OTC: GWHP) to Announce that Global is Now Offering the AstraZeneca Vaccines for $17.50 Per Vaccine as Mentioned in 8k Filing 03/08/21

Retrieved on: 
Tuesday, March 9, 2021
Vaccination, Vaccine, Virology, Medical specialties, World Health Organization, Health, United Nations response to the COVID-19 pandemic, World Health Organization's response to the COVID-19 pandemic

Under Mr. Strongos direction, Global is following the President and his leadership and is making a war on COVID.

Key Points: 
  • Under Mr. Strongos direction, Global is following the President and his leadership and is making a war on COVID.
  • Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest line of COVID 19 tests.
  • Now, with the vaccine, Global is offering one of the largest lines of products to fight this virus.
  • Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID.

Global WholeHealth Partners Corp (OTC:GWHP) to Announce that Global is Now Offering the AstraZeneca Vaccines as Mentioned in 8K Filing on 03/02/21

Retrieved on: 
Monday, March 8, 2021
World Health Organization, Presidency of Donald Trump, COVID-19 pandemic in the United States, Presidency of Joe Biden, World Health Organization's response to the COVID-19 pandemic, United Nations response to the COVID-19 pandemic

Now, with the vaccine, Global is offering one of the largest lines of products to fight this virus.

Key Points: 
  • Now, with the vaccine, Global is offering one of the largest lines of products to fight this virus.
  • https://philadelphia.cbslocal.com/2021/01/21/president-joe-biden-country...
    Under Mr. Strongos direction, Global is following the President and his leadership and is making a war on COVID.
  • To conquer COVID and win this war, Global must keep up the research and development of tests.
  • Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID.

Yicai: WHO Says Rich Countries Should Fulfill Their Promise of Providing Vaccines Fairly

Retrieved on: 
Monday, March 1, 2021
Infectious diseases, General Health, Pharmaceutical, Health, World Health Organization, COVID-19, Tedros Adhanom, Ghebreyesus, Medical specialties, COVAX, Vaccine, Health, Medical research, World Health Organization's response to the COVID-19 pandemic, COVID-19 vaccine

Secretary-General Tedros Adhanom Ghebreyesus accused rich countries of competing for various vaccines in large quantities, but few vaccines were delivered to underdeveloped countries.

Key Points: 
  • Secretary-General Tedros Adhanom Ghebreyesus accused rich countries of competing for various vaccines in large quantities, but few vaccines were delivered to underdeveloped countries.
  • Tedros said that some rich countries deal directly with manufacturers, and the number of vaccines distributed to third world countries through COVAX agreement is decreasing.
  • Only when rich countries respect COVAX's agreement can COVAX member countries get vaccines."
  • Governments, vaccine manufacturers and the international community need to take urgent actions to fulfill the promise of providing vaccines fairly.

Statement of the members of the European Council on COVID-19 and health, 25 February 2021

Retrieved on: 
Friday, February 26, 2021
Articles, Biotechnology, Vaccination, Pandemic, Vaccine, World Health Organization's response to the COVID-19 pandemic, Vaccination policy

We are determined to continue to work together and coordinate our action to tackle the pandemic and its consequences.

Key Points: 
  • We are determined to continue to work together and coordinate our action to tackle the pandemic and its consequences.
  • We must therefore uphold tight restrictions while stepping up efforts to accelerate the provision of vaccines.
  • The unhindered flow of goods and services within the Single Market must be ensured, including by making use of Green Lanes.
  • Even so, we need to urgently accelerate the authorisation, production and distribution of vaccines, as well as vaccination.
  • We call for work to continue on a common approach to vaccination certificates and will come back to this issue.
  • We reaffirm our solidarity with third countries and underline our determination to step up our global response to the pandemic.
  • We will continue to keep the overall situation under close review and take action as needed.

II. HEALTH

    • Although the COVID-19 crisis is not yet over, it is time to start strengthening our future health resilience now.
    • We will work to improve EU coordination, in line with the Union competences under the Treaties, to ensure better prevention, preparedness for and response to future health emergencies.
    • Work on the Health Union proposals and on the Pharmaceutical Strategy, including as regards access to medicines across Member States, should also be taken forward.
    • We are committed to advancing global health security, including by strengthening the World Health Organization and working towards an international treaty on pandemics within its framework.
    • In this context, we look forward to the G20 Global Health Summit in Rome.

Article - Coronavirus: a timeline of EU action in 2021

Retrieved on: 
Thursday, February 18, 2021
Contemporary history, Health, Articles, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, World Health Organization's response to the COVID-19 pandemic, COVID-19 vaccine

Check out our timeline to find out how the EU is tackling the impact of the coronavirus pandemic in 2021.

Key Points: 

Check out our timeline to find out how the EU is tackling the impact of the coronavirus pandemic in 2021.
Discover what action the EU is taking in 2021 for the roll-out of vaccines and treatment, to boost the economy, employment, society, travel and transport and to help its partners worldwide to fight Covid-19.

Respiratory Virus Vaccines R&D Focused on COVID-19 Efforts: Fact.MR

Retrieved on: 
Thursday, February 18, 2021
Medical specialties, Health, Medicine, Occupational safety and health, Vaccination, Vaccine, Virology, Coronavirus disease, COVID-19 vaccine, World Health Organization's response to the COVID-19 pandemic

NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Award winning market research company has published a report on the global respiratory virus vaccines market .

Key Points: 
  • NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Award winning market research company has published a report on the global respiratory virus vaccines market .
  • As per the study, R&D on respiratory vaccines is focused on COVID-19 at the moment, however, the long-term outlook remains positive.
  • Learning from the impact of COVID-19, governments around the globe are focusing on developing adequate treatment options for respiratory vaccines.
  • Fact.MR, in its new offering, presents an unbiased analysis of the global respiratory virus vaccines market.

Respiratory Virus Vaccines R&D Focused on COVID-19 Efforts: Fact.MR

Retrieved on: 
Thursday, February 18, 2021
Medical specialties, Health, Medicine, Occupational safety and health, Vaccination, Vaccine, Virology, Coronavirus disease, COVID-19 vaccine, World Health Organization's response to the COVID-19 pandemic

NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Award winning market research company has published a report on the global respiratory virus vaccines market .

Key Points: 
  • NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Award winning market research company has published a report on the global respiratory virus vaccines market .
  • As per the study, R&D on respiratory vaccines is focused on COVID-19 at the moment, however, the long-term outlook remains positive.
  • Learning from the impact of COVID-19, governments around the globe are focusing on developing adequate treatment options for respiratory vaccines.
  • Fact.MR, in its new offering, presents an unbiased analysis of the global respiratory virus vaccines market.

Survey: COVID-19 Pandemic Is Advancing Healthcare Technology

Retrieved on: 
Monday, January 25, 2021
Articles, Assistive technology, Telehealth, World Health Organization, COVID-19 pandemic, World Health Organization's response to the COVID-19 pandemic, Face masks during the COVID-19 pandemic

64% think that COVID-19 has advanced healthcare technology.

Key Points: 
  • 64% think that COVID-19 has advanced healthcare technology.
  • In a health pandemic, 83% are more aware of their health and the health of those around them because of COVID-19.
  • 64%think that COVID-19 has advanced healthcare technology and they are embracing it.
  • 81% of those who have used telemedicine during the pandemic, said they will continue doing so once the pandemic is over.

New Data Shows Nurses and Their Families are at Significantly Higher Risk for COVID-19 Infection and Hospitalization Vs. General Public

Retrieved on: 
Wednesday, October 21, 2020
Occupational safety and health, Health, Articles, Coronavirus disease, Zoonoses, Nursing, Human rights issues related to the COVID-19 pandemic, World Health Organization's response to the COVID-19 pandemic

The studies show that patient-facing nurses and their households have a three- and two-fold increased risk of COVID-19 hospitalization, respectively.

Key Points: 
  • The studies show that patient-facing nurses and their households have a three- and two-fold increased risk of COVID-19 hospitalization, respectively.
  • It concluded that frontline nurses had a three-fold risk of COVID-19 hospitalization, and their family members had a two-fold risk over the general population.
  • Data 2 published by the National Institutes of Health shows that among U.S. healthcare personnel with COVID-19, nurses are disproportionately affected.
  • Another study 3, published in Lancet Public Health, shows that frontline healthcare nurses are at an increased risk for reporting a positive COVID-19 test, compared to the general public.